• Product NameXylometazoline hydrochloride
• Brief DescriptionInhibitors
• Purification99.05%
• Biological ActivityXylometazoline Hydrochloride is an α-adrenoceptor agonist commonly used as nasal decongestant.
• Target NameAdrenergic Receptor agonist
• CAS No. 1218-35-5
• Calculated MW 280.84
• Formulation C16H24N2HCl
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Endocrine system
  SMILES:Cl.CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C
  Pathways:GPCR/G Protein
  Receptor:α1A-adrenergic receptor; α1B-adrenergic receptor; α1D-adrenergic receptor; α2A-adrenergic receptor; α2B-adrenergic receptor; α2C-adrenergic receptor
  Boling pt:394.2C
  Melting pt:131-133 C
  Solubility:Ethanol: 56 mg/mL (199.4 mM); Water: 56 mg/mL (199.4 mM); DMSO: 27 mg/mL (96.14 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Haenisch B, Fundam Clin Pharmacol, 2010, 24(6), 729-739.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting